Inoviq Ltd has released a press release.
BARD1 Awarded BTB Funding to Develop Breast Cancer Test
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Inoviq
- Appendix 4E and Annual Report to Shareholders
- European Patent Validated
- Quarterly Business Update & Appendix 4C
- BARD1 completes Sienna acquisition
- Quarterly Activities Report & Appendix 4C
Later from Inoviq
- Successful BARD1 Kit Evaluation
- BARD1 Gains New High-volume Customer for its hTERT Test
- AGM & CEO Presentations and Chairmans Transcript
- Outstanding SubB2M Ovarian Cancer Test Data
- Excellent SubB2M Breast Cancer Test Data
Follow Inoviq into a list and get an email when it puts out news.
Follow Inoviq